跳至主要内容
临床试验/NCT03344237
NCT03344237Unknown不适用

High-Sensitivity Cardiac Troponin T in Patients Admitted to the Emergency Department With Atrial Fibrillation in the Era of Novel Oral Anticoagulants - Heidelberg Registry of Atrial Fibrillation

University Hospital Heidelberg1 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2017年9月14日最近更新:
适应症

试验速览

阶段
不适用
入组人数
5,000
试验地点
1
主要终点
Vascular and non-vascular death

研究概览

简要总结

The purpose of the Heidelberg Registry of Atrial Fibrillation (HERA-FIB) is to collect data on the prevalence and clinical significance of elevated cardiac troponin in a large registry of unselected patients with atrial fibrillation presenting to an emergency department in the era of novel oral anticoagulants (NOACs).

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • documented atrial fibrillation
  • availability of at least one hsTnT measurement

排除标准

  • 未提供

结局指标

主要结局

Vascular and non-vascular death

时间窗: Follow up after at least 6 months

Stroke/systemic embolism

时间窗: Follow up after at least 6 months

Nonfatal myocardial infarction

时间窗: Follow up after at least 6 months

次要结局

  • Stroke, systemic embolism, myocardial infarction, vascular death, non-vascular death, composite endpoint of vascular and non-vascular death, nonfatal MI, stroke/systemic embolism(Follow up after at least 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr.med. Dr.med.univ. Mehrshad VAFAIE

Cardiologist

University Hospital Heidelberg

研究点 (1)

Loading locations...

相似试验